Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gamma Lactam. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free synthesis of polycyclic gamma-lactams offers cost reduction and scalable supply for antitumor drug manufacturing pipelines globally.
Patent CN110004081A details a novel biocatalytic route for gamma-lactam. This method ensures high optical purity and offers significant supply chain cost reduction advantages.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel catalyst-free synthesis of spiro-gamma-lactams via Ugi reaction. Reduces metal contamination risks and simplifies purification for pharmaceutical intermediates.
Novel C-H amination method for gamma/delta-lactams offers high selectivity and cost-effective routes for complex API intermediates.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Patent CN111925356A discloses stable chiral ligands enabling high-yield nickel-catalyzed lactam synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.